Luxembourg vs Portugal: Access to anti-retroviral drugs, male
Luxembourg
83.0%
in 2024
Portugal
82.0%
in 2017
Luxembourg rank
40th
Portugal rank
42nd
Access to anti-retroviral drugs, male over time
- Luxembourg
- Portugal
How they compare
Luxembourg currently reports 83.0% against 82.0% in Portugal, a difference of 1.0%.
The two have swapped places 1 time across 18 shared years of data; in 2000 it was Luxembourg ahead.
Luxembourg ranks 40th and Portugal ranks 42nd of 141 countries.
Across the 2 decades both report, Luxembourg averaged higher in 1 and Portugal in 1.
Head to head by decade
| Decade | Luxembourg | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.0% | 30.8% | 14.2% | Luxembourg |
| 2010s | 61.9% | 63.9% | 2.0% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Luxembourg or Portugal?
- Luxembourg, at 83.0% against 82.0% in Portugal as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Luxembourg and Portugal?
- 1.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Portugal?
- 18 years are reported by both, from 2000 to 2017.
- How do Luxembourg and Portugal rank globally for access to anti-retroviral drugs, male?
- Luxembourg ranks 40th and Portugal ranks 42nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.